ABR-238901
ABR-238901 is an oral, active S100A8/A9 blocker that inhibits the binding of S100A8/A9 to RAGE and TLR4 receptors. It shows potential for myocardial infarction treatment and is applied in cardiovascular research, including in vitro assays and in vivo models of cardiac injury.
Product Specifications
CAS Number
1638200-22-2
Product Name Alternative
ABR 238901, ABR238901, ABR-238901, TLR4, S100A8/A9
Field of Research
Immunology & Inflammation, Neuroscience
Purity
98.63% (May vary between batches)
Solubility
H2O:0.1 mg/mL (0.25 mM) ; DMSO:30 mg/mL (76.02 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.07 mM)
Smiles
COc1ncc (cc1Br) S (=O) (=O) Nc1cncc (Cl) c1O
Molecular Formula
C11H9BrClN3O4S
Molecular Weight
394.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6175971-01 0.1 mL
ID3 (Inhibitor of DNA Binding 3, Dominant Negative Helix-loop-Helix Protein, HEIR-1, bHLHb25) (FITC)
Sign In for Pricing
View Details